Tommi Kainu, a management consultant, is to join Bavarian Nordic A/S on 1 July to fill the newly created position of chief business officer as the Danish company advances its lead cancer therapy towards registration. Dr Kainu will join from the Boston Consulting Group (BCG) where he has been a partner and managing director since 2011.
Prior to this, he worked at the National Human Genome Research Institute which is part of the US National Institutes of Health. Dr Kainu holds MD and PhD degrees from the University of Tampere Medical School in Finland.
Bavarian Nordic announced the appointment on 10 May 2017.
Copyright 2017 Evernow Publishing Ltd